or
forgot password
  • cancer clinical trials in ann arbor, MI

  • Care Partners: Web-based Support for Caregivers of Veterans Undergoing Chemotherapy
    VA Ann Arbor Healthcare System
    Ann Arbor, Michigan 48113
    Cancer
    Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)
    University of Michigan Medical Center
    Ann Arbor, Michigan 48104-0914
    Acute Myeloid Leukemia
    Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Urothelial Cancer, Bladder Cancer
    Study of Tissue and Blood Samples From Patients With High-Grade Glioma
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Brain and Central Nervous System Tumors
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Colorectal Cancer, Precancerous Condition
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma
    C.S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Neuroblastoma
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Preoperative Soy Isoflavone Supplementation in the Prevention of Head and Neck Squamous Carcinoma
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Squamous Carcinoma
    Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Breast Cancer
    Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Multiple Myeloma
    Aspirin in Reducing Events in the Elderly
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Functional Disability, Dementia, Heart Disease, Stroke, Cancer, Bleeding
    Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Lung Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    Saint Joseph Mercy Hospital
    Ann Arbor, Michigan 48106
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma
    Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha
    University of Michigan Cancer Center
    Ann Arbor, Michigan 48109
    Chronic Myeloid Leukemia
    Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatosplenic T-cell Lymphoma, HIV-associated Hodgkin Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
    Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
    University of Michigan Cancer Center
    Ann Arbor, Michigan 48109
    Cancer, Solid Tumors, Lymphoma, Malignancy
    Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
    The University of Michigan - Comprehensive Cancer Center
    Ann Arbor, Michigan 48109
    Relapsed Multiple Myeloma
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Liver Cancer
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Malignant Mesothelioma
    Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
    Saint Joseph Mercy Cancer Center
    Ann Arbor, Michigan 48106-0995
    Breast Cancer
    Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Anaplastic Carcinoma of the Gallbladder, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Saint Joseph Mercy Cancer Center
    Ann Arbor, Michigan 48106-0995
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Cervical Cancer, Endometrial Cancer, Sarcoma
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    University of Michigan Health System-Cancer Center
    Ann Arbor, Michigan 48109
    Breast Cancer
    Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Breast Cancer
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    University of Michigan Medical Center
    Ann Arbor, Michigan 48104-0914
    Multiple Myeloma
    Everolimus Versus Placebo in Head and Neck Cancer
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Head and Neck Cancer
    Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Ovarian Endometrioid Adenocarcinoma, Ovarian Papillary Serous Carcinoma, Ovarian Serous Cystadenocarcinoma, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Triple-negative Breast Cancer
    Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
    University of Michigan Cancer Center
    Ann Arbor, Michigan 48109
    Solid Tumor Malignancies
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Kidney Cancer